BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

   
POLYPURE INTRODUCES KEY MONODISPERSED PEG COMPOUND

Maleimidopropionyl-PEG significantly enhances assay and drug optimisation

Oslo, Norway, October 17, 2007
– Following successful customer trials, the Scandinavian-based PEG specialist Polypure has launched its latest monodispersed PEG derivative – Maleimidopropionyl-PEG NHS ester. This heterobifunctional PEG is designed to improve crosslinking between compounds carrying amino groups and thiol functions and is attracting widespread interest from both diagnostic and pharmaceutical developers.

According to Polypure Marketing Director Magali Le Bomin, this new PEG fully demonstrates the increasingly acknowledged benefits of monodispersed PEGs: “The polymer homogeneity achieved by using our patented Sample Displacement Chromatographic purification method ensures a high level of functional integrity. Likewise, the single molecular weight avoids the characterisation problems of polydispersed polymer mixtures. Looking at applications, for diagnostics we can significantly improve cross-linking, binding and lots reproducibility. Similarly for pharmaceuticals, the extended PEG space length enhances the solubility of poorly soluble drugs. Furthermore, there is the overriding benefit of being able to reduce diagnostic and drug design complexity which has a significant impact on development, regulatory and production times.”

-ends-

About Polypure As
The Scandinavian based company Polypure is a world leader in the design and manufacture of monodispersed PEG derivatives for advanced technologies. Our quality standards ensure their successful use in research and industrial applications in nanotechnology, biotechnology and in pharmaceutical sciences. The compounds are produced by using a proprietary purification technology that is both cost efficient and can be readily scaled up to meet an increase in product demand.
The company has been in operation since 1999. The business strategy relies on a focused product development to meet the demand for state of the art derivatives. We support the global market with our stock items, as well as custom synthesis products for specific applications. Our standard PEG catalogue products are distributed by major chemical distributors and are represented worldwide through agents in Europe, USA and Japan.
www.polypure.no

PRESS RELEASE Ref Polypure 01.07

Corporate Inquiries
Magali Le Bomin
Polypure As
Oslo Research Park, N-0349 Oslo, Norway
Tel ++47 22 95 83 29 Email:
magali.lebomin@polypure.no

Media Inquiries
Richard Hayhurst, Hayhurst Media
Tel +44 (0) 7711821527 Email:
Richard@hayhurstmedia.com

 


 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.